234 related articles for article (PubMed ID: 2403385)
1. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.
Tiegs G; Niehörster M; Wendel A
Biochem Pharmacol; 1990 Sep; 40(6):1317-22. PubMed ID: 2403385
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Tiegs G; Wolter M; Wendel A
Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
[TBL] [Abstract][Full Text] [Related]
3. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
Lehmann V; Freudenberg MA; Galanos C
J Exp Med; 1987 Mar; 165(3):657-63. PubMed ID: 3819645
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.
Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yasuda M; Yamanaka T; Katayama K
Immunopharmacol Immunotoxicol; 1991; 13(4):485-98. PubMed ID: 1774433
[TBL] [Abstract][Full Text] [Related]
5. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
Endo Y; Kikuchi T; Nakamura M
Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
[TBL] [Abstract][Full Text] [Related]
6. Colchicine prevents tumor necrosis factor-induced toxicity in vivo.
Tiegs G; Freudenberg MA; Galanos C; Wendel A
Infect Immun; 1992 May; 60(5):1941-5. PubMed ID: 1563785
[TBL] [Abstract][Full Text] [Related]
7. O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays.
Liu J; Saavedra JE; Lu T; Song JG; Clark J; Waalkes MP; Keefer LK
J Pharmacol Exp Ther; 2002 Jan; 300(1):18-25. PubMed ID: 11752092
[TBL] [Abstract][Full Text] [Related]
8. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats.
Bahrami S; Redl H; Leichtfried G; Yu Y; Schlag G
Infect Immun; 1994 Jan; 62(1):99-105. PubMed ID: 8262655
[TBL] [Abstract][Full Text] [Related]
9. Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver.
Wang JF; Wendel A
Biochem Pharmacol; 1990 Jan; 39(2):267-70. PubMed ID: 2302253
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
[TBL] [Abstract][Full Text] [Related]
11. A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor alpha in vivo.
Neihörster M; Inoue M; Wendel A
Biochem Pharmacol; 1992 Mar; 43(5):1151-4. PubMed ID: 1554388
[TBL] [Abstract][Full Text] [Related]
12. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.
Ulich TR; del Castillo J; Ni RX; Bikhazi N
J Leukoc Biol; 1989 Jun; 45(6):546-57. PubMed ID: 2786048
[TBL] [Abstract][Full Text] [Related]
13. Protection by sinomenine against endotoxin-induced fulminant hepatitis in galactosamine-sensitized mice.
Kondo Y; Takano F; Yoshida K; Hojo H
Biochem Pharmacol; 1994 Aug; 48(5):1050-2. PubMed ID: 8093093
[TBL] [Abstract][Full Text] [Related]
14. Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
Fukuda T; Mogami A; Tanaka H; Yoshikawa T; Hisadome M; Komatsu H
Life Sci; 2006 Jul; 79(9):822-7. PubMed ID: 16626762
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Wang H; Xu DX; Lv JW; Ning H; Wei W
Toxicology; 2007 Jul; 237(1-3):49-57. PubMed ID: 17602819
[TBL] [Abstract][Full Text] [Related]
18. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
Mignon A; Rouquet N; Fabre M; Martin S; Pagès JC; Dhainaut JF; Kahn A; Briand P; Joulin V
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1308-15. PubMed ID: 10194182
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality.
Oberholzer A; Oberholzer C; Bahjat FR; Edwards CK; Moldawer LL
J Endotoxin Res; 2001; 7(5):375-80. PubMed ID: 11753206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
